A prospective study of the immune system activation biomarker neopterin and colorectal cancer risk

Journal of the National Cancer Institute

Volumn 107, Issue 4, 2015, Pages

  Aleksandrova, Krasimira ^a   Chuang, Shu Chun ^b,c   Boeing, Heiner ^a   Zuo, Hui ^d   Tell, Grethe S ^d   Pischon, Tobias ^e   Jenab, Mazda ^f   Bueno De Mesquita, Bas ^b,g,h   Vollset, Stein Emil ^d,i   Midttun, Øivind ^j   Ueland, Per Magne ^d,k   Fedirko, Veronika ^l,m   Johansson, Mattias ^f   Weiderpass, Elisabete ^n,o,p,q   Severi, Gianluca ^r   Racine, Antoine ^s,t,u   Boutron Ruault, Marie Christine ^s,t,u   Kaaks, Rudolf ^v   Kühn, Tilman ^v   Tjønneland, Anne ^w   Overvad, Kim ^x   Quirós, J Ramón ^y   Jakszyn, Paula ^z   Sánchez, María José ^aa,ab   Dorronsoro, Miren ^ac   Chirlaque, Maria Dolores ^ab,ad   Ardanaz, Eva ^ab,ae   Khaw, Kay Tee ^af   Wareham, Nicholas J ^af   Travis, Ruth C ^ag   Trichopoulou, Antonia ^ah,ai   Lagiou, Pagona ^ai,aj   Trichopoulos, Dimitrios ^ah,ai,aj   Palli, Domenico ^ak   Sieri, Sabina ^al   Tumino, Rosario ^am   Panico, Salvatore ^an   May, Anne M ^ao   Palmqvist, Richard ^h   Ljuslinder, Ingrid ^ap   Kong, So Yeon J ^f   Freisling, Heinz ^f   Gunter, Marc J ^b   Lu, Yunxia ^b   Cross, Amanda J ^b   Riboli, Elio ^b   Vineis, Paolo ^b,r   more..

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d UNIVERSITY OF BERGEN   (Norway)

^e MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^f INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^g NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^h UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

ⁱ NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^j BEVITAL AS   (Norway)

^k HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^l EMORY UNIVERSITY   (United States)

^m EMORY UNIVERSITY   (United States)

ⁿ UNIVERSITY OF TROMSØ   (Norway)

^o CANCER REGISTRY OF NORWAY   (Norway)

^p KAROLINSKA INSTITUTE   (Sweden)

^q FOLKHÄLSAN RESEARCH CENTER   (Finland)

^r Human Genetics Foundation (HuGeF)   (Italy)

^s INSERM   (France)

^t UNIVERSITÉ PARIS SACLAY   (France)

^u IGR   (France)

^v GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^w DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^x AARHUS UNIVERSITY   (Denmark)

^y Public Health Directorate   (Spain)

^z CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^aa ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^ab CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^ac Basque Regional Health Department   (Spain)

^ad Murcia Regional Health Authority   (Spain)

^ae INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^af UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ag UNIVERSITY OF OXFORD   (United Kingdom)

^ah BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^ai UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^aj HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^ak HELLENIC HEALTH FOUNDATION   (Greece)

^al CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^am NATIONAL CANCER INSTITUTE   (Italy)

^an Cancer Registry and Histopathology Unit Civile MPArezzo Hospital Ragusa   (Italy)

^ao UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^ap UMEÅ UNIVERSITY   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

7,8 DIHYDRONEOPTERIN; BIOLOGICAL MARKER; NEOPTERIN; UNCLASSIFIED DRUG; 7,8-DIHYDRONEOPTERIN; TUMOR MARKER;

ADULT; ARTICLE; CANCER RISK; CELLULAR IMMUNITY; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNE SYSTEM; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; AGED; ANALOGS AND DERIVATIVES; BLOOD; CASE CONTROL STUDY; COLON TUMOR; COLORECTAL TUMOR; EUROPE; HELPER CELL; IMMUNOLOGY; LIQUID CHROMATOGRAPHY; ODDS RATIO; RECTUM TUMOR; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

ADULT; AGED; BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; CHROMATOGRAPHY, LIQUID; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; EUROPE; FEMALE; HUMANS; IMMUNITY, CELLULAR; MALE; MIDDLE AGED; NEOPTERIN; ODDS RATIO; PROSPECTIVE STUDIES; RECTAL NEOPLASMS; SENSITIVITY AND SPECIFICITY; T-LYMPHOCYTES, HELPER-INDUCER; TANDEM MASS SPECTROMETRY;

EID: 84930701125     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djv010     Document Type: Article

References (47)

1. Grizzi F, Bianchi P, Malesci A, et al. Prognostic value of innate and adaptive immunity in colorectal cancer. World J Gastroenterol. 2013;19(2):174-184.
2. Boland CR, Luciani MG, Gasche C, et al. Infection, inflammation, and gastrointestinal cancer. Gut. 2005;54(9):1321-1331.
3. Huber C, Batchelor JR, Fuchs D, et al. Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J Exp Med. 1984;160(1):310-316.
4. Murr C, Widner B, Wirleitner B, et al. Neopterin as a marker for immune system activation. Curr Drug Metab. 2002;3(2):175-187.
5. Spencer ME, Jain A, Matteini A, et al. Serum levels of the immune activation marker neopterin change with age and gender and are modified by race, BMI, and percentage of body fat. J Gerontol A Biol Sci Med Sci. 2010;65(8):858-865.
6. Frick B, Schroecksnadel K, Neurauter G, et al. Increasing production of homocysteine and neopterin and degradation of tryptophan with older age. Clin Biochem. 2004;37(8):684-687.
7. Wirleitner B, Schroecksnadel K, Winkler C, et al. Neopterin in HIV-1 infection. Mol Immunol. 2005;42(2):183-194.
8. Berdowska A, Zwirska-Korczala K. Neopterin measurement in clinical diagnosis. J Clin Pharm Ther. 2001;26(5):319-329.
9. Sucher R, Schroecksnadel K, Weiss G, et al. Neopterin, a prognostic marker in human malignancies. Cancer Lett. 2010;287(1):13-22.
10. Hoffmann G, Wirleitner B, Fuchs D. Potential role of immune system activation-associated production of neopterin derivatives in humans. Inflamm Res. 2003;52(8):313-321.
11. Murr C, Fuith LC, Widner B, et al. Increased neopterin concentrations in patients with cancer: indicator of oxidative stress? Anticancer Res. 1999;19(3A):1721-1728.
12. Blasko I, Knaus G, Weiss E, et al. Cognitive deterioration in Alzheimer's disease is accompanied by increase of plasma neopterin. J Psychiatr Res. 2007;41(8):694-701.
13. Oxenkrug G, Tucker KL, Requintina P, et al. Neopterin, a Marker of Interferon-Gamma-Inducible Inflammation, Correlates with Pyridoxal-5'-Phosphate, Waist Circumference, HDL-Cholesterol, Insulin Resistance and Mortality Risk in Adult Boston Community Dwellers of Puerto Rican Origin. Am J Neuroprot Neuroregen. 2011;3(1):48-52.
14. Murr C, Winklhofer-Roob BM, Schroecksnadel K, et al. Inverse association between serum concentrations of neopterin and antioxidants in patients with and without angiographic coronary artery disease. Atherosclerosis. 2009;202(2):543-549.
15. Ip M, Rainer TH, Lee N, et al. Value of serum procalcitonin, neopterin, and C-reactive protein in differentiating bacterial from viral etiologies in patients presenting with lower respiratory tract infections. Diagn Microbiol Infect Dis. 2007;59(2):131-136.
16. Zuo H, Tell GS, Vollset SE, et al. Interferon-gamma-induced inflammatory markers and the risk of cancer: The Hordaland Health Study. Cancer. 2014;In press.
17. Wei EK, Giovannucci E, Wu K, et al. Comparison of risk factors for colon and rectal cancer. Int J Cancer. 2004;108(3):433-442.
18. Slimani N, Kaaks R, Ferrari P, et al. European Prospective Investigation into Cancer and Nutrition (EPIC) calibration study: rationale, design and population characteristics. Public Health Nutr. 2002;5(6B):1125-1145.
19. Riboli E, Kaaks R. The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol. 1997;26(Suppl 1):S6-S14.
20. Riboli E, Hunt KJ, Slimani N, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr. 2002;5(6B):1113-1124.
21. International Statistical Classification of Diseases and Related Health Problems, Tenth Revision-ICD-10. In. 2 ed. Geneva, Switzerland: World Health Organisation, 2004.
22. Rinaldi S, Rohrmann S, Jenab M, et al. Glycosylated hemoglobin and risk of colorectal cancer in men and women, the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev. 2008;17(11):3108-3115.
23. Haftenberger M, Lahmann PH, Panico S, et al. Overweight, obesity and fat distribution in 50-to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr. 2002;5(6B):1147-1162.
24. Midttun O, Hustad S, Ueland PM. Quantitative profiling of biomarkers related to B-vitamin status, tryptophan metabolism and inflammation in human plasma by liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 2009;23(9):1371-1379.
25. Werner ER, Fuchs D, Hausen A, et al. Simultaneous determination of neopterin and creatinine in serum with solid-phase extraction and on-line elution liquid chromatography. Clin Chem. 1987;33(11):2028-2033.
26. Fuchs D, Milstien S, Kramer A, et al. Urinary neopterin concentrations vs total neopterins for clinical utility. Clin Chem. 1989;35(12):2305-2307.
27. Aleksandrova K, Jenab M, Boeing H, et al. Circulating C-reactive protein concentrations and risks of colon and rectal cancer: a nested case-control study within the European Prospective Investigation into Cancer and Nutrition. Am J Epidemiol. 2010;172(4):407-418.
28. Jenab M, Riboli E, Cleveland RJ, et al. Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2007;121(2):368-376.
29. van Duijnhoven FJ, Bueno-De-Mesquita HB, Calligaro M, et al. Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition. Gut. 2011;60(8):1094-1102.
30. Leufkens AM, van Duijnhoven FJ, Woudt SH, et al. Biomarkers of oxidative stress and risk of developing colorectal cancer: a cohort-nested case-control study in the European Prospective Investigation Into Cancer and Nutrition. Am J Epidemiol. 2012;175(7):653-663.
31. Refsum H, Nurk E, Smith AD, et al. The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease. J Nutr. 2006;136(6 Suppl):1731S-1740S.
32. Prentice RL BN. Retrospective studies and failure time models. Biometrika. 1978;65:153-158.
33. Lunn M, McNeil D. Applying Cox regression to competing risks. Biometrics. 1995;51(2):524-532.
34. Hronek M, Zadak Z, Solichova D, et al. The association between specific nutritional antioxidants and manifestation of colorectal cancer. Nutrition. 2000;16(3):189-191.
35. Weiss G, Kronberger P, Conrad F, et al. Neopterin and prognosis in patients with adenocarcinoma of the colon. Cancer Res. 1993;53(2):260-265.
36. Melichar B, Solichova D, Melicharova K, et al. Urinary neopterin in patients with advanced colorectal carcinoma. Int J Biol Markers. 2006;21(3):190-198.
37. Ledochowski M, Murr C, Widner B, et al. Inverse relationship between neopterin and immunoglobulin E. Clin Immunol. 2001;98(1):104-108.
38. Rogers LM, Olivier AK, Meyerholz DK, et al. Adaptive immunity does not strongly suppress spontaneous tumors in a Sleeping Beauty model of cancer. J Immunol. 2013;190(8):4393-4399.
39. Koudougou C, Bonneville M, Matysiak-Budnik T, et al. Review article: antitumoural immunity in colorectal cancer-current and potential future implications in clinical practice. Aliment Pharmacol Ther. 2013;38(1):3-15.
40. Hadden JW. Immunodeficiency and cancer: prospects for correction. Int Immunopharmacol. 2003;3(8):1061-1071.
41. Denz H, Fuchs D, Hausen A, et al. Value of urinary neopterin in the differential diagnosis of bacterial and viral infections. Klin Wochenschr. 1990;68(4):218-222.
42. Collins D, Hogan AM, Winter DC. Microbial and viral pathogens in colorectal cancer. Lancet Oncol. 2011;12(5):504-512.
43. Shachar I, Karin N. The dual roles of inflammatory cytokines and chemokines in the regulation of autoimmune diseases and their clinical implications. J Leukoc Biol. 2013;93(1):51-61.
44. Romagnani S. Type 1 T helper and type 2 T helper cells: functions, regulation and role in protection and disease. Int J Clin Lab Res. 1991;21(2):152-158.
45. Thewissen MM, Damoiseaux JG, Duijvestijn AM, et al. Abdominal fat mass is associated with adaptive immune activation: the CODAM Study. Obesity (Silver Spring). 2011;19(8):1690-1698.
46. Midttun O, Townsend MK, Nygard O, et al. Most blood biomarkers related to vitamin status, one-carbon metabolism, and the kynurenine pathway show adequate preanalytical stability and within-person reproducibility to allow assessment of exposure or nutritional status in healthy women and cardiovascular patients. J Nutr. 2014;144(5):784-790.
47. Zavoral M, Suchanek S, Zavada F, et al. Colorectal cancer screening in Europe. World J Gastroenterol. 2009;15(47):5907-5915.